Pulmonary Function Testing Devices Market Statistics

2022

Pulmonary Function Testing Devices Market

by Product (Portable PFT Devices, Complete PFT Devices), by Test Type (Spirometry, Peak flow meter, Lung Volume Test, Gas Exchange Testing, Maximal Voluntary Ventilation, Others), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, Restrictive Lung Disease, Others), by End user (Hospital, Clinical laboratories, Diagnostic Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

LS : Medical Devices & Supplies	Report Code: A03407	Sep 2022 \| Pages: 341
Tables: 200	Charts: 68	Formats*: Single User License, Five User License & Enterprise User License Data Pack Excel License It comes with the additional cost of $2500.00 contact sales.

Pulmonary Function Testing Devices Market Research, 2031

The global Pulmonary Function Testing Devices Market size market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. Pulmonary function testing is a series of tests that can determine as well as measure the efficacy of inhaling and exhaling functions performed by the lungs. It plays a pivotal role in determining the efficient transfer of oxygen into the blood and helps in diagnosing certain types of lung diseases such as asthma, bronchitis, and emphysema, along with determining the cause of shortness of breath. Some of the common types of pulmonary function tests are spirometry, which measures how much air a person can breathe in and out. It also measures how fast a person can empty the air out of their lungs. This test is done to check how well the oxygen moves from the lungs into the bloodstream.

The overall impact of COVID-19 remains positive on pulmonary function testing system market. Coronavirus causes a huge effect on the lungs and hence the demand for medical equipment or device increases to keep the lung healthy owing to increase in demand of pulmonary test to diagnose the disease or to check the efficacy of the lungs. Furthermore, pandemic increases the demand for pulmonary function test (PFT) tool as it is a valuable tool in the assessment of respiratory disease. Spirometry is the key diagnostic test for airway diseases such as asthma and chronic obstructive pulmonary disease (COPD), and is the most commonly performed test. The other tests include lung volumes and diffusing capacity measurement, impulse oscillometry (IOS), bronchoprovocation, and exercise physiology tests

Pulmonary Function Testing Devices Market, Pulmonary Function Testing Devices Market size, Pulmonary Function Testing Devices Market share, Pulmonary Function Testing Devices Market trends, Pulmonary Function Testing Devices Market growth, Pulmonary Function Testing Devices Market analysis, Pulmonary Function Testing Devices Market forecast, Pulmonary Function Testing Devices Market opportunity

The key factors that drive the Pulmonary Function Testing Devices Market growth are the rise in the prevalence of lung cancer and lung-related disorders; rise in the geriatric population; and the increase in the adoption of technologically advanced medical devices across the world. In addition, rise in the demand for minimally invasive tests for lung diseases is the key factor that boosts the market growth. For instance, according to the World Health Organization, in 2020, chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide. It was estimated that around 3.9 million people died due to COPD. Furthermore, the increase in the geriatric population and the rise in the prevalence of chronic lung diseases have increased the demand for pulmonary function testing devices for disease diagnosis across the world which further boosts the Pulmonary Function Testing Devices Market growth.

Moreover, an increase in R&D activity for pulmonary function testing devices, and a rise in healthcare expenditures further boost the growth of the market. However, the high cost of medical devices and a lack of awareness of pulmonary tests hamper the market growth. Conversely, the emerging healthcare market in developing countries is expected to provide Pulmonary Function Testing Devices Market opportunity for the key players during the forecast period.

The global Pulmonary Function Testing Devices Market size market was valued at $1.9 billion in 2021, and is projected to reach $3.5 billion by 2031, growing at a CAGR of 6.4% from 2022 to 2031. TIn addition, the market is segmented on the basis of test type, application, product, end user and region. By test type the market is segmented into spirometry, peak flow meter, lung volume, gas exchange testing, maximal voluntary ventilation and others. On the basis of application, it is segmented into chronic obstructive pulmonary disorders, asthma, chronic shortness of breath, restrictive lung disease, and others. On the basis of product, it is segmented into portable PFT devices and complete PFT systems. By end user the market is segmented into hospitals, diagnostic centers, clinical laboratories, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Product Segment Review

By product, the market is segmented into portable PFT device and complete PFT system, the portable PFT device segment exhibited the largest Pulmonary Function Testing Devices Market share in 2021 and is anticipated to lead during the forecast period. Owing to the rise in the prevalence of lung cancer and other lung-related disorder which increases the demand of non-invasive tests that measure the capacity of lungs. The complete PFT system segment is anticipated to grow at a significant rate during the forecast period.